Primary Recipient

AZEVAN PHARMACEUTICALS INC

Amount

$226,385.00

Award Date

9/30/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

A POTENTIAL NEW DRUG FOR DEPRESSION Additional support was requested to broaden the scope of R44 MH063663, A Potential New Drug for Depression, an active SBIR Phase IIa award. The requested funds will allow additional characterization studies of three ne